RegenX LLC — National Science Foundation SBIR Phase I: BT
RegenX LLC — SBIR Phase I award from National Science Foundation.
- Amount
- $255,947
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- BT
- NAICS
- —
- Place of performance
- MA
- Period
- 2020-09-15 → 2021-08-31
Description
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop safe and affordable COVID-19 vaccination technology, with broader utility in preventing other types of outbreak in the future. This nov